Protopine, a novel microtubule-stabilizing agent, causes mitotic arrest and apoptotic cell death in human

Related Experiment Video

Updated: May 28, 2026

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells
15:53

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells

Published on: August 21, 2013

Chun-Han Chen1, Cho-Hwa Liao, Ya-Ling Chang

  • 1Pharmacological Institute, College of Medicine, National Taiwan University, Taipei, ROC.

Cancer Letters
|October 29, 2011
PubMed

Insights

Protopine, a natural compound, shows anticancer effects against hormone-refractory prostate cancer (HRPC) by stabilizing microtubules and inducing apoptosis. It halts cancer cell proliferation by targeting key cell cycle regulators and mitochondria-mediated pathways.

Area of Science:

  • Pharmacology
  • Cell Biology
  • Oncology

Background:

  • Prostate cancer, particularly hormone-refractory prostate cancer (HRPC), remains a significant clinical challenge.
  • Identifying novel therapeutic agents with distinct mechanisms of action is crucial for improving patient outcomes.

Purpose of the Study:

  • To investigate the anticancer effects of protopine on human hormone-refractory prostate cancer (HRPC) cells.
  • To elucidate the underlying molecular mechanisms of protopine's anti-cancer activity.

Main Methods:

  • Cell proliferation assays to assess anti-proliferative effects.
  • Analysis of tubulin polymerization and mitotic arrest.
  • Western blotting to evaluate the expression and phosphorylation of key proteins involved in apoptosis and cell cycle regulation (e.g., Cdk1, cyclin B1, Bcl-2, Mcl-1).

Main Results:

  • Protopine demonstrated significant anti-proliferative effects on HRPC cells.
  • The compound induced mitotic arrest through the polymerization of tubulin.
  • Protopine promoted apoptotic cell death by modulating mitochondria-mediated signaling pathways, including Bcl-2 phosphorylation and Mcl-1 down-regulation.
  • Increased activity of the cyclin-dependent kinase 1 (Cdk1)/cyclin B1 complex was observed.

Conclusions:

  • Protopine acts as a novel microtubule stabilizer with potent anticancer activity against HRPC cells.
  • The anti-cancer effects are mediated through the induction of apoptosis via modulation of Cdk1 activity and Bcl-2 family proteins.
  • Protopine represents a potential therapeutic candidate for hormone-refractory prostate cancer.

More Related Videos

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on: September 8, 2017

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.